Non-hodgkin lymphoma - causes, symptoms, diagnosis, treatment, pathology
What is non-hodgkin lymphoma? Non-hodgkin lymphoma is a type of lymphoma characterized by the absence of Reed-Sternberg cells. Find more videos at ...
Osmosis
Cancer Vet Reviews A Chemo Treatment Option: Vlog 101
Doxorubicin is a very commonly used chemotherapy drug in dogs and cats. It is used in combination chemotherapy protocols and also as a single agent protocol ...
Dr Sue Cancer Vet
Chemotherapy Unit
setrustMedia
Chemotherapy Myths & Misconceptions: VLOG 42
Myth busting time! What are the 8 most common chemotherapy myths & misconceptions for dogs and cats? Plus a bonus at the end :) Update: I am no longer ...
Dr Sue Cancer Vet
Oral Therapies and Adherence in Lymphoma and CLL Webinar – February 22, 2020
The Lymphoma Research Foundation is the nation's largest non-profit organization devoted to funding innovative research and providing people with lymphoma ...
Lymphoma Research Foundation
Can We Cure Lymphoma in Dogs? VLOG 74
In this video, Dr. Sue is back in the clinic checking on her patients. She is especially excited to report on her patient Pokey, who she have been treating for over 2 ...
Dr Sue Cancer Vet
Debate: Watch and Wait in Follicular Lymphoma: Should We Treat Immediately?
Earn CME: https://www.naccme.com/program/19-lm-11 In this webcast from the 'Moving Forward in the Treatment of Relapsed/Refractory Follicular Lymphoma: ...
ImedexCME
Chemotherapy Product Animation
INFUGEM is a chemotherapy product indicated for ovarian cancer, breast cancer, non-small cell lung cancer (NSCLC) and pancreatic cancer. It is the first ...
Random42 Scientific Communication
Follicular Lymphoma Treatment Options
Dr. Brian Link of the University of Iowa discusses treatment options for follicular lymphoma (FL). To learn more about follicular lymphoma, visit the Lymphoma ...
Lymphoma Research Foundation
Oral Cancer: A Comprehensive Overview
The presentation provides participants with a comprehensive review of oral cavity cancer, including information about the warning signs of oral malignancy and ...
UNC Cancer Network
Herbs, Botanicals, and Supplements during Cancer Treatment | Memorial Sloan Kettering
Many herbs, botanicals, and dietary supplements are known to have powerful biological effects, but these effects are not well studied. Integrative medicine ...
Memorial Sloan Kettering
5.1 Cancer and Chemotherapy 1
PHRM203
Taking the Complication out of Chemotherapy by Dr. Maxwell M. Krem
Dr. Krem presents this lecture by first describing chemotherapy indications and which patients should receive chemotherapy. He then explains common toxicities ...
UofL Internal Medicine Lecture Series
Chemotherapy 101 | Donna Gairns, Lymphoma Nurse Director
Chemotherapy 101 – the basics of what you need to know Presented by Donna Gairns, National Nurse Manager, Lymphoma Australia Donna Gairns, National ...
Lymphoma Australia
New Agents for Mantle Cell Lymphoma
Earn CME: https://www.naccme.com/program/19-lm-15 In this webcast from the 'New and Emerging Agents in MCL' symposium during the 2019 Lymphoma ...
ImedexCME
ASH 2010: Key research presented at ASH 2010
Prof George Canellos, Harvard Medical School, Boston, USA, talks about the key research that has emerged from the 2010 ASH meeting in Florida. One trial of ...
ecancer
Can we use Patient-derived Xenografts to Assess New Lymphoma Therapies?
For the past fifteen years, Lymphoma & Myeloma has been the premier forum on the latest advances in lymphoma, myeloma, and other plasma cell neoplasms.
ImedexCME
Medicines in Development - Leukemia & Lymphoma
Biopharmaceutical companies are developing 241 medicines for blood cancers - leukemia, lymphoma and myeloma. These medicines in development offer ...
PhRMAPress
New Cancer Treatments and Diagnostic Updates in Dogs & Cats: Vlog 75
What is New in Cancer Treatment and Diagnostics in Dogs & Cats? Every year Dr Sue attends state of the art veterinary conferences to get the latest scientific ...
Dr Sue Cancer Vet
What are the most promising new approaches and agents for T cell lymphoma?
In this presentation from Lymphoma & Myeloma 2016, Jia Ruan discusses the most promising new approaches and agents for the treatment of T cell lymphoma.
ImedexCME
5.3 Cancer and Chemotherapy 1
Get the notes: http://www.lulu.com/product/paperback/phrm-203/16453879 The lecture notes for this and all numbered lectures are available at Lulu.com, ...
PHRM203
What is the Best Approach to the Initial Therapy of Peripheral T-cell Lymphoma?
For the past fifteen years, Lymphoma & Myeloma has been the premier forum on the latest advances in lymphoma, myeloma, and other plasma cell neoplasms.
ImedexCME
Future Directions in T Cell Cutaneous Lymphoma
Overview of future directions in diagnosing and treating cutaneous lymphoma.
CutaneousLymphomaFnd
CNS involvement and prophylaxis in acute lymphoblastic leukaemia
Dr Mark Litzow talks to ecancer at the European School of Haematology (ESH) meeting: International Conference on Acute Lymphoblastic Leukaemia about the ...
ecancer
Unmet Needs for Metastatic Breast Cancer
Mark Pegram, MD, highlights the unmet needs and considerations for patients with metastatic breast cancer, including the need for improved cytotoxic ...
OncLiveTV
Breast Cancer Update | Dr. Cary Hsu - UCLA Health
UCLA Health - Health Lectures http://uclahealth.org/calendar.
UCLA Health
New and future treatments, Dr Paul Fields
Dr Paul Fields, Consultant Haematologists, Guy's and St Thomas' NHS Foundation Trust talks about new and future treatments at the Lymphoma Association ...
Lymphoma Action
Cutaneous Lymphoma and Skin Maintenance
Clinical Research Fellow Tara Jennings from the Thomas Jefferson University provides guidelines for skin maintenance as it relates to cutaneous lymphoma.
CutaneousLymphomaFnd
Chemotherapy for Brain and Spine Tumors: Why Do We Use It and What to Expect
This interactive webinar is presented by Dr. Marta Penas-Prado, Associate Research Physician with NCI/Neuro-Oncology Branch (NOB) in Washington, DC.
American Brain Tumor Association
Keynote speaker: Understanding the monitoring and safety of IBD medications and biologics
Earn CME credit for this activity: https://naccme.com/program/7318 In this Keynote presentation from the Clinical Track at the 2018 Advances in Inflammatory ...
ImedexCME
Acute Myeloid Leukemia - Diagnosis and Treatment in 2020
In this webcast, Dr. Florian Kuchenbauer will explain modern approaches to classification and treatment of acute myeloid leukemia. He will further discuss ...
The Leukemia & Lymphoma Society of Canada
Dog Lymphoma Chemotherapy Options Part Two: Vlog 88
In part 2 of this 2 part series, Dr Sue continues to break down some of the most common lymphoma chemotherapy protocols. Be sure to check out part one, ...
Dr Sue Cancer Vet
Webinar: Caring for Immunocompromised Patient
Dr. Paul Richardson presents Living with and Caring for Immunocompromised Patients in the COVID-19 Era, for the families and friends of adults with cancer.
Dana-Farber Cancer Institute
Dr. Paul Richardson on novel approaches for treating multiple myeloma | Dana-Farber Cancer Institute
Paul G. Richardson, MD, summarizes novel agents and combinations used for treating multiple myeloma. Key strategies include targeting protein degradation, ...
Dana-Farber Cancer Institute
FACEBOOK Live: Treatments for Advanced Disease - Jennifer DeSimone, MD
July 2018 - Dr. Jennifer DeSimone of Inova Melanoma and Skin Cancer Center, and Susan Thornton, of the Cutaneous Lymphoma Foundation, discuss ...
CutaneousLymphomaFnd
Viral lymphomas: risk factors and treatments
Viruses such Epstein-Barr virus (EBV) and HIV have been aetiologically linked to a significant number of lymphoproliferative diseases. In this roundtable ...
VJHemOnc – Video Journal of Hematological Oncology
Understanding Chronic Lymphocytic Leukemia with Anthony Mato, MD
Anthony Mato, MD gives a deep dive into Chronic Lymphocytic Leukemia. About Dr. Mato: Anthony Mato, MD Memorial Sloan Kettering Cancer Center.
Lymphoma Research Foundation
Understanding the Link Between Scleroderma and Cancer- Laura K. Hummers, M.D., Sc.M.- 2018
While studies have suggested that the risk of cancer might be increased in scleroderma patients, the reason for this association has not been well understood.
Scleroderma Foundation
2014 Ft Lauderdale PEF - Cutaneous Lymphoma: Biology and Treatment
An overview of cutaneous lymphoma and its treatment from the CLF's Patient Educational Forum in Ft. Lauderdale on November 15, 2014.
CutaneousLymphomaFnd
Treatment Evolution in Newly Diagnosed Hodgkin Lymphoma
Course Director, Anas Younes, MD, discusses Hodgkin lymphoma in this CME activity titled "Treatment Evolution in Newly Diagnosed Hodgkin Lymphoma: A ...
PeerView Oncology
The Treatment Landscape of Chronic Lymphocytic Leukemia
Perspectives on how the standard treatment of chronic lymphocytic leukemia (CLL) has shifted from chemotherapy to novel approaches. View more at ...
curetoday
Challenges in diagnosing and treating CTCL
With cutaneous T-cell lymphoma (CTCL) being a rare disease with an incredibly high prevalence, Pierluigi Porcu, MD, from Sidney Kimmel Cancer Center, ...
VJHemOnc – Video Journal of Hematological Oncology
